Articles

Real-world validation study of the LSC17 score for risk prediction in patients with newly diagnosed acute myeloid leukemia

Princess Margaret Cancer Centre, University Health Network, Toronto, ON
Department of Biological Chemistry, School of Medicine, University of California, Irvine (UCI), Irvine, California
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON
Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Ontario M<sup>5</sup>G 2M9, Canada; Department of Medicine, University of Toronto, Toronto, Ontario M5G 1A1
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Ontario M<sup>5</sup>G 2M9, Canada; Department of Medicine, University of Toronto, Toronto, Ontario M5G 1A1
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Ontario M<sup>5</sup>G 2M9, Canada; Department of Medicine, University of Toronto, Toronto, Ontario M5G 1A1
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Ontario M<sup>5</sup>G 2M9, Canada; Department of Medicine, University of Toronto, Toronto, Ontario M5G 1A1
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Ontario M<sup>5</sup>G 2M9, Canada; Department of Medicine, University of Toronto, Toronto, Ontario M5G 1A1
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Ontario M<sup>5</sup>G 2M9, Canada; Department of Medicine, University of Toronto, Toronto, Ontario M5G 1A1
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Ontario M<sup>5</sup>G 2M9, Canada; Department of Medicine, University of Toronto, Toronto, Ontario M5G 1A1
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Ontario M<sup>5</sup>G 2M9, Canada; Department of Medicine, University of Toronto, Toronto, Ontario M5G 1A1
Princess Margaret Cancer Centre, University Health Network, Toronto, ON
Princess Margaret Cancer Centre, University Health Network, Toronto, ON
Juravinski Cancer Centre, Hamilton, ON
The Ottawa Blood Disease Centre, The Ottawa Hospital, Ottawa, ON
Juravinski Cancer Centre, Hamilton, ON, Canada; Department of Medicine, McMaster University, Hamilton, ON
The Ottawa Blood Disease Centre, The Ottawa Hospital, Ottawa, ON
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Ontario M<sup>5</sup>G 2M9, Canada; Department of Medicine, University of Toronto, Toronto, Ontario M5G 1A1
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Biological Chemistry, School of Medicine, University of California, Irvine (UCI), Irvine, California
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, Ontario M<sup>5</sup>G 2M9, Canada; Department of Medicine, University of Toronto, Toronto, Ontario M5G 1A1
Haematologica Early view Jul 10, 2025 https://doi.org/10.3324/haematol.2025.287777